자궁경암의 자궁강내 Radium 및 Co60에 의한 치료성적 - 1963년부터 1979년까지의 임상적 분석 -

From 1963 through 1979, 368 patients with carcinoma of the uterine cervix were treated with Intracavitary Radium and Co60 at Cancer Research Hospital, Seoul, Korea. The purpose of this report was to analyze the clinical data and survival rate of these patients. The results were as follows: 1. The clinical stage of 368 patients treated with ICR and Co60 were as follows; Stage IB, 32 cases(8.7%), IIA, 135 cases(36.7%), IIB 169 cases(45.9%), Ⅲ, 25 cases(6.8%), Ⅳ, 3 cases(0.8%), and Postoperation recurrent, 4 cases(1.1%). 2. The most frequent distribution of age was 41~50. 3. The results of histopathologic subtype were distributed as follows: Squamous cell carcinoma was 96.7%, Adenocarcinoma was 2.7% and Adenosquamous carcinoma was 0.5%. 4. The 5-year survival rates by stage in confirmed patients by follow up were Stage IB, 88.0%, IIA, 75.2%, IIB, 69.3%, Ⅲ, 55.0%, Ⅳ, 0%, and Postoperation recurrent, 50.0%. 5. The 10-year survival rates by stage in confirmed patients by follow up were Stage IB, 75.0%, IIA, 69.0%, IIB, 50.0%, Ⅲ, 30.0%, and Ⅳ, 0%.